Berlin-based tech company Clare&me has raised €3.7 million in funding for its clinical large language model (CLLM), underlining the company’s vision to develop non-judgemental mental health support to “close the gap between the demand and supply”.
The solution allows individuals seeking mental health support to schedule regular calls with ‘Clare’, an an artificial intelligence designed to be an “empathetic and non-judgemental listener”, capable of guiding users through a series of prompts to help them understand more about their mental health challenges.
According to the company’s website, the AI merges cognitive behavioural therapy principles and aspects of mindfulness and positive psychology, with content “curated by psychologists and overseen by” advisors.
Co-founder Emilia Theye has shared plans for the new funding to help accelerate technical development, expand the team, scale operations, and build partnerships with clinics.
In other news on German health tech, we recently took a look at Universitätsklinikum Hamburg-Eppendorf’s Future Plan 2050, which outlines the hospital’s plans for smart buildings, robotics, and AI. Plans also include the construction of a centre for translational immunology; a biobank to store “around 10 million” tissue samples for research; an S3 laboratory; a new University Heart and Vascular Centre featuring innovative tech including AI and robotics; and a University Cancer Centre and Centre for Imaging, to offer diagnostics and therapies under one roof.
In the wider European context, the AI Act recently entered into force, setting out clear requirements and obligations in support of “trustworthy AI”, help mitigate risks created by AI applications, put in place enforcement and governance structure at European and national level, and set out obligations for both deployers and providers of AI applications.
- 1
- 2
